“Shift Toward Rapid, Point-of-Care Testing and Automation”
- One prominent trend in the global HIV and hepatitis testing market is the increasing shift toward rapid, point-of-care (POC) testing and automation in diagnostics
- These innovations enable faster, more accessible, and cost-effective screening, particularly in resource-limited settings, by eliminating the need for centralized laboratories and reducing turnaround times for results
- For instance, rapid diagnostic tests (RDTs) for HIV and hepatitis C can deliver accurate results within minutes using minimal equipment, allowing for immediate clinical decisions and reducing patient drop-off
- Automation in laboratory-based testing has also gained traction, enhancing throughput, consistency, and reliability of results—especially valuable for high-volume screening in public health programs
- This trend is transforming disease management strategies by promoting early detection, improving linkage to care, and expanding testing reach, thereby fueling the demand for innovative and efficient diagnostic solutions across global markets
